Market Research Logo

Conference Documentation: Parallel Trade

Conference Documentation: Parallel Trade

Pharmaceutical Parallel Trade in the European Union is a large and growing phenomenon.

Different regulatory regimes for pharmaceuticals result in significant differences in pharmaceutical prices across countries. These prices make it profitable for Parallel Trade to take place in addition to PT reaching a significant proportion of total national pharmaceutical expenditure in many European countries, particularly those with high pharmaceutical prices such as UK, Germany, the Netherlands and Sweden. But the issue of pharmaceutical Parallel Trade continues to generate controversy among stake holders and has become an issue of intense debate in the global trading system.

Europe’s leading Parallel Trade Conference will focus on assessing pricing strategies and the impact of parallel trade on the generics market and vice versa. In addition, there will be three open floor round table discussions drawing attention to the ongoing debate; is parallel trade justified? Stakeholder engagement and competition law effects will be discussed, in addition to a breakfast briefing on assessing data collection… and that’s just to start with.

Patient safety is first and foremost when it comes to the implementation of the Anti-Counterfeit Directive and this will be addressed. What will follow is assessing the repackaging and re-boxing of products. Further topics to be evaluated include case studies on the implementation of best practices and the outcomes to be reviewed on parallel trade, are they positive or negative?

The note to end on will be… What’s the future of Parallel Trade?


Day 1
8:30
Registration & Coffee
9:00
Chairman's Opening Remarks
Eric Noehrenberg , Director, Regional Market Access lead, Shire GmbH
9:10
Overview of Parallel Trade and its impact
Eric Noehrenberg , Director, Regional Market Access lead, Shire GmbH
9:50
Session reserved for the EAEPC
Heinz Kobelt, Director European Affairs, European Association of Euro-Pharmaceutical Companies
10:30
Morning Coffee
11:00
Assessing pricing strategies for parallel trade
Janice Haigh, Practice Leader, Market Access, Quintiles (UK) Ltd
11:40
KEYNOTE ADDRESS: Initiatives of Parallel Distributors in the context of Falsified Medicines Directive
Tomasz Dzitko, Founder and CEO , Delfarma
12:20
Networking Lunch
13:30
Parallel Trade in Germany – Situation and perspective
Bertram Häussler, Chairman of the Board of Management, IGES Institut GmbH
14:10
The Impact and Future of Parallel Trade
Patrick O'Neill-Ortiz, Managing Director, Parallel Pharma Ltd
14:50
Afternoon Tea
15:20
Case Study 1: The role of the pharmacists in parallel trade defined
Leyla Hannbeck, Head of Pharmacy, The National Pharmaceutical Association Ltd
16:00
Case Study 2: The concept transferred to the implementation
Shan Hassam, Group Director, Veenak International Ltd
16:40
Chairman’s Closing Remarks and Close of Day One
Eric Noehrenberg , Director, Regional Market Access lead, Shire GmbH
Day 2
8:30
Registration & Coffee
9:00
Chairman's Opening Remarks
Eric Noehrenberg , Director, Regional Market Access lead, Shire GmbH
9:10
EU perspective for Parallel Trade
Suzanne Elvidge, Specialised writer in healthcare, pharmaceuticals and busines, None
9:50
Supply chain protection and patient safety
John Jolley, Director, MPCC Global Regulatory Solutions
10:30
Morning Coffee
11:00
Market Outlook and Macro Dynamics
Shabnam Hanassab, Consultant, IMS Health
11:40
Effects of parallel trade on affordable access to medicines in the EU
Dermot Glynn, Senior Adviser, Europe Economics
12:20
Networking Lunch
13:30
KEYNOTE ADDRESS - Intellectual Property Update
Christopher Stothers, Partner, Arnold and Porter
14:10
Patient Safety – Fighting the Fakes
Mike Isles, Executive Director, European Alliance for Access to Safe Medicines
14:50
Afternoon Tea
15:20
Government intervention in exporting countries, a new trend?
Antonio Mendonca Alves, CEO, MD Pharma SA
16:00
ROUND TABLE DISCUSSION - A clear divide still stands - The Big Debate!
Antonio Mendonca Alves, CEO, MD Pharma SA
16:00
ROUND TABLE DISCUSSION - A clear divide still stands - The Big Debate!
Tomasz Dzitko, Founder and CEO , Delfarma
16:40
Chairman’s Closing Remarks and Close of Day Two
Eric Noehrenberg , Director, Regional Market Access lead, Shire GmbH

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report